These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26450660)

  • 41. Development and validation of a Clostridium difficile infection risk prediction model.
    Dubberke ER; Yan Y; Reske KA; Butler AM; Doherty J; Pham V; Fraser VJ
    Infect Control Hosp Epidemiol; 2011 Apr; 32(4):360-6. PubMed ID: 21460487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes in community-acquired Clostridium difficile infection.
    Khanna S; Pardi DS; Aronson SL; Kammer PP; Baddour LM
    Aliment Pharmacol Ther; 2012 Mar; 35(5):613-8. PubMed ID: 22229532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
    Ananthakrishnan AN; Guzman-Perez R; Gainer V; Cai T; Churchill S; Kohane I; Plenge RM; Murphy S
    Aliment Pharmacol Ther; 2012 Apr; 35(7):789-95. PubMed ID: 22360370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clostridium difficile infection in hospitalized children in the United States.
    Nylund CM; Goudie A; Garza JM; Fairbrother G; Cohen MB
    Arch Pediatr Adolesc Med; 2011 May; 165(5):451-7. PubMed ID: 21199971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of hospital-onset Clostridium difficile infection in the New York metropolitan region using a collaborative intervention model.
    Koll BS; Ruiz RE; Calfee DP; Jalon HS; Stricof RL; Adams A; Smith BA; Shin G; Gase K; Woods MK; Sirtalan I
    J Healthc Qual; 2014; 36(3):35-45. PubMed ID: 23294050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.
    Barker AK; Alagoz O; Safdar N
    Clin Infect Dis; 2018 Apr; 66(8):1192-1203. PubMed ID: 29112710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hospital-onset Clostridium difficile infection among solid organ transplant recipients.
    Donnelly JP; Wang HE; Locke JE; Mannon RB; Safford MM; Baddley JW
    Am J Transplant; 2015 Nov; 15(11):2970-7. PubMed ID: 26484839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes.
    Haines CF; Moore RD; Bartlett JG; Sears CL; Cosgrove SE; Carroll K; Gebo KA
    AIDS; 2013 Nov; 27(17):2799-807. PubMed ID: 23842125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring Clostridium difficile infection in an acute hospital: prevalence or incidence studies?
    Lavan AH; McCartan DP; Downes MM; Hill AD; Fitzpatrick F
    Ir J Med Sci; 2012 Sep; 181(3):315-20. PubMed ID: 22350440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.
    Kumar S; Metz DC; Kaplan DE; Goldberg DS
    Am J Gastroenterol; 2020 May; 115(5):716-722. PubMed ID: 32356953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study.
    Brown KA; Fisman DN; Moineddin R; Daneman N
    PLoS One; 2014; 9(8):e105454. PubMed ID: 25157757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
    PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
    Almutairi MS; Gonzales-Luna AJ; Alnezary FS; Fallatah SB; Alam MJ; Begum K; Garey KW
    Anaerobe; 2021 Dec; 72():102440. PubMed ID: 34461273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electronic health record-based detection of risk factors for Clostridium difficile infection relapse.
    Hebert C; Du H; Peterson LR; Robicsek A
    Infect Control Hosp Epidemiol; 2013 Apr; 34(4):407-14. PubMed ID: 23466915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.